Memorial Sloan Kettering Cancer Center (MSKCC), often referred to simply as Memorial Sloan Kettering, is a leading institution in the field of oncology, headquartered in New York City, US. Founded in 1884, it has established itself as a pioneer in cancer treatment, research, and education, with a commitment to advancing the understanding and management of cancer. MSKCC operates multiple facilities across the US, providing comprehensive cancer care that includes innovative therapies, cutting-edge clinical trials, and personalised treatment plans. Its unique approach combines world-class medical expertise with a focus on patient-centred care, making it a trusted name in the industry. Notable achievements include being consistently ranked among the top cancer hospitals in the nation, reflecting its strong market position and dedication to improving patient outcomes.
How does Memorial Sloan Kettering Cancer Center's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Memorial Sloan Kettering Cancer Center's score of 18 is lower than 69% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2021, Memorial Sloan Kettering Cancer Center (MSKCC) reported its carbon emissions data, although specific figures for total emissions in kg CO2e were not disclosed. The organisation has not provided detailed information on Scope 1, 2, or 3 emissions, nor has it outlined any specific reduction targets or achievements. MSKCC has not cascaded emissions data from any parent organisation, indicating that its climate commitments and emissions reporting are independent. Currently, there are no stated climate pledges or initiatives aimed at reducing carbon emissions. As a leading cancer treatment and research institution in the US, MSKCC's approach to climate action remains to be defined, particularly in the context of the healthcare sector's growing emphasis on sustainability and carbon footprint reduction.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Memorial Sloan Kettering Cancer Center has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
